Status:
COMPLETED
Bone Pain Score Validation Initiative
Lead Sponsor:
iOMEDICO AG
Conditions:
Bone Metastasis
Eligibility:
All Genders
18+ years
Brief Summary
Translation and validation of the BOMET-QoL-10 questionnaire in Germany and assessment of its validity and responsiveness.
Detailed Description
Aim of this study is to translate the questionnaire and to examine the psychometric properties of BOMET-QoL-10 in a German population. Correlations with the EORTC QLQ-C30/BM22 at the time of enrolment...
Eligibility Criteria
Inclusion
- Male or female adults patients (≥ 18 years)
- Diagnosed cancer of the breast, kidney, lung or prostate
- Bone metastases
- Estimated life expectancy of at least 6 months
- Fluent German speaking, reading and writing
- Informed written consent
Exclusion
- Patients without bone metastases
- Participation in another study involving questionnaires
- Patients not able to comply with the assessments specified in the protocol
Key Trial Info
Start Date :
December 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
370 Patients enrolled
Trial Details
Trial ID
NCT02293642
Start Date
December 1 2014
End Date
June 1 2016
Last Update
August 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Multiple Sites All Over Germany
Multiple Locations, Germany